JO
YTEN

John Overdeck’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

John Overdeck’s Portfolio YTEN Stock Details YTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-822
Closed -$168K – 4855
2021
Q2 		$168K Sell
822
-487
-37% -$108K ﹤0.01% 3823
2021
Q1 		$394K Buy
1,309
+401
+44% +$136K ﹤0.01% 3136
2020
Q4 		$126K Buy
+908
New +$138K ﹤0.01% 3189

Other funds holding YTEN

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

John Overdeck's YTEN Position: Q3 2021 in Review

John Overdeck sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q3 2021, closing a stake of 822 shares — an estimated $168K sold.

John Overdeck first reported a position in YTEN in Q4 2020 and held it in 3 quarters. The position peaked at $394K in Q1 2021. 13 funds tracked by Wall St. Rank hold YTEN as of Q3 2021.

  • John Overdeck reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • John Overdeck sold 822 Yield10 Bioscience, Inc. Common Stock shares in Q3 2021, an estimated $168K.
  • John Overdeck first reported a position in Yield10 Bioscience, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
  • John Overdeck's Yield10 Bioscience, Inc. Common Stock position peaked at $394K in Q1 2021.
  • 13 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q3 2021.

Based on Two Sigma Investments's 13F filing for Q3 2021, filed 15 Nov 2021.